Breakpoint Therapeutics aims to advance the clinical improvement of 1st-in-class oncology medications that interfere with DNA repair service and replication strain tolerance pathways. The company’s therapeutics focus on the DNA hurt reaction in most cancers cells with mend and replication anxiety tolerance pathways, enabling the health care organisation and hospitals https://is.gd/VVmTMJ